Update: Truist Ups Price Target on NVIDIA to $145 From $140 on Improving Fundamentals, Reiterates Buy Rating
Jefferies Adjusts Price Target on Eli Lilly to $1,113 From $1,050
Craig-Hallum Maintains NVIDIA(NVDA.US) With Buy Rating
BofA Securities Maintains Apple(AAPL.US) With Buy Rating, Maintains Target Price $256
Wedbush Maintains Apple(AAPL.US) With Buy Rating, Maintains Target Price $285
Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,106
BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101
Eli Lilly Price Target Maintained With a $1106.00/Share by Morgan Stanley
A Quick Look at Today's Ratings for NVIDIA(NVDA.US), With a Forecast Between $145 to $175
A Quick Look at Today's Ratings for Apple(AAPL.US), With a Forecast Between $250 to $285
Eli Lilly Analyst Ratings
Morgan Stanley Reiterates Overweight on Eli Lilly, Maintains $1106 Price Target
Truist Securities Maintains Buy on NVIDIA, Raises Price Target to $145
Apple Is Maintained at Outperform by Evercore ISI Group
Apple Price Target Maintained With a $256.00/Share by B of A Securities
Loop Capital Maintains Meta Platforms(META.US) With Buy Rating, Maintains Target Price $575
iPhone Upgrade Cycle May Unleash 'Long Awaited Renaissance of Growth:' Wedbush
Apple Analyst Ratings
Melius Research Reiterates Buy on Apple, Maintains $265 Price Target
Wolfe Research Maintains Microsoft(MSFT.US) With Buy Rating, Cuts Target Price to $495